Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 156,719 | 452,049 | 131,612 | 226,577 | 133,814 |
| Cost of Goods | 2,338 | 4,151 | 1,463 | 3,829 | 1,071 |
| Gross Profit | 154,381 | 447,898 | 130,149 | 222,748 | 132,743 |
| Operating Expenses | 314,901 | 308,233 | 277,472 | 334,398 | 281,470 |
| Operating Income | -160,182 | 139,816 | -146,860 | -110,821 | -148,656 |
| Interest Expense | 22,164 | 22,762 | 22,930 | 22,861 | 22,694 |
| Other Income | 53,953 | 6,477 | 22,968 | 26,644 | 27,249 |
| Pre-tax Income | -128,393 | 123,531 | -146,822 | -107,038 | -144,101 |
| Income Tax | 213 | -20 | 116 | -2,689 | -3,621 |
| Net Income Continuous | -128,606 | 123,551 | -146,938 | -104,349 | -140,480 |
| Net Income | $-128,606 | $123,551 | $-146,938 | $-104,349 | $-140,480 |
| EPS Basic Total Ops | -0.80 | 0.78 | -0.93 | -0.66 | -0.95 |
| EPS Basic Continuous Ops | -0.81 | 0.78 | -0.93 | -0.66 | -0.95 |
| EPS Diluted Total Ops | -0.80 | 0.70 | -0.93 | -0.66 | -0.95 |
| EPS Diluted Continuous Ops | -0.81 | 0.68 | -0.93 | -0.66 | -0.95 |
| EPS Diluted Before Non-Recurring Items | -0.80 | 0.70 | -0.93 | -0.66 | -0.95 |
| EBITDA(a) | $-159,113 | $141,046 | $-146,929 | $-113,330 | $-150,625 |